Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
All cancer types
Closed
Phase 1
A trial for people with solid tumours that have spread () and that have a change on the cMET gene. A is any type of cancer apart from those of the blood or lymphatic system such as or .
This trial is looking at how a drug called INC280 changes the way caffeine and midazolam are broken down by the body.
Recruitment start: 16 June 2016
Recruitment end: 22 November 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Moditha Nawinne
Novartis
Last reviewed: 21 June 2016
CRUK internal database number: 14111